netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Search
 Formulary Chapter 23: Shared Care Guideline - Full Chapter
Notes:

Group

Title

Chapter

 

Chapter 1 - Gastro-intestinal system

 

3Ts

Azathioprine/Mercaptopurine tablets

1

3Ts

Azathioprine tablets (Imuran)

1

3Ts

Sulfasalazine tablets (Salazopyrin EN-tabs)

1

 

Chapter 2 - Cardiovascular system

 

BCAP

Colesevelam (Cholestagel) 'off label' - treatment of bile salt malabsorption

2

BCAP

Dronedarone (Multaq) - treatment of AF

2

SFT/GWH

Dronedarone (Multaq) - treatment of AF

2

RUH DOACS for the OFF-LABEL treatment of cancer associated thrombosis RUH PATIENTS ONLY

RUH

LMWH for the OFF-LABEL treatment of cancer associated thrombosis RUH patients ONLY

 2

SFT

Midodrine Hydrochloride (Bramox) - treatment of Postural Hypotension

2

 

Chapter 3 - Respiratory

 

BCAP

Nebulised Colistimethate for non-Cystic Fibrosis (non-CF) bronchiectasis

3

 

Chapter 4 - Central Nervous system

 

 

Note: For ADHD in paeds and adolescents, scroll down to Chapter 16

 

BSW

BaNES and Wilts Methylphenidate, Atomoxetine and Lisdexamfetamine - adult ADHD treatment

4

3Ts

Acamprosate (Campral) - treatment of alcohol dependence

4

3Ts

Aripiprazole (Ability) - treatment of schizophenia and prevention of mania

4

3Ts

Donepezil, Rivastigmine and Galantimine - treatment of Alzheimer's disease

4

3Ts

Eslicarbazepine - treatment of partical onset seizures

4

3Ts

Lamotrigine (Lamictal) - prevention of depressive episodes in bipolar disorder

4

3Ts

Lithium - treatment and prophylaxis of manis, bipolar disorder and depression

4

3Ts

Lithium (signature sheet)

4

3Ts

Memantine - treatment of moderate to severe Alzheimer's disease

4

3Ts

Naltrexone - treatment of Alcohol dependence

4

3Ts

Naltrexone for Alcohol signature sheet

4

3Ts

Naltrexone for Opiate dependence

4

3Ts

Naltrexone for Opiates signature sheet

4

3Ts

Oromucosal Midazolam - over 10s

4

3Ts

Oromucosal Midazolam - under 10s

4

3Ts

Valproic Acid - treatment of manic episode in bipolar disorder

4

BCAP

Acamprosate - treatment of alcohol dependence

4

BCAP

Donepezil, Rivastigmine and Galantamine - treatment of dementia

4

BCAP

Drug & Alcohol Service

4

BCAP

Eslicarbazepine (Zebinix) - treatment of partial onset seizures in adults

4

BCAP

Lithium

4

BCAP

Memantine

4

BCAP

Memory Asessment Referral

4

BCAP

Oromucosal Midazolam - over 10s

4

BCAP

Oromucosal Midazolam - under 10s

4

BCAP

Perampanel - treatment of partial-onset seizures

4

BCAP

Rotigotine - treatment of Parkinson's disease

4

SFT

Buccal Midazolam - intervention for prolonged seizures

4

SFT

Dementia drugs

4

SFT

Lithium - treatment and prophylaxis of manis, bipolar disorder and depression

4

SFT

Oromucosal Midazolam - over 10s

4

SFT

Oromucosal Midazolam - under 10s

4

 

Chapter 5 - Infections

 

3Ts

Rifaximin - reduction of episodes of hepatic encephalopathy in adults

5

BCAP

Rifaximin - reduction of episodes of hepatic encephalopathy in adults

5

SFT

Rifaximin - reduction of episodes of hepatic encephalopathy in adults

5

 

Chapter 6 - Endocrine system

 

3Ts

Denosumab - treatment of postmenopausal osteoporosis

6

3Ts

Growth Hormone (Somatropin) - Children

6

BCAP

Denosumab - treatment of postmenopausal osteoporosis

6

BCAP

Gender Dysphoria in Transmen (Female to Male)

6

BCAP

Gender Dysphoria in Transwomen (Male to Female)

6

BCAP

Growth Hormone (Somatropin) - Adults

6

BSW

Liothyronine - combination treatment of hypothyroidism

6

BCAP

Octreotide - management of Carcinoid Syndrome

6

BCAP

Testosterone replacement in men

6

SFT

Denosumab

6

 

Chapter 8 - Malignant disease and immunosuppression

 

BSW

Ibandronic acid - Adjuvant therapy for postmenopausal patients with early breast cancer

8

3Ts

Ciclosporin - treatment od severe rheumatoid arthritis

8

3Ts

Hydroxycarbamide - treatment of myeloproliferative neoplasms

8

3Ts

Methotrexate - treatment of rheumatoid arthritis and other inflammatory arthritis

8

BCAP

Methotrexate injections - for use in dermatology and rheumatology

8

GWH

Subcutaneous methotrexate injection Shared Care Document (Rheumatology)

 

SFT

Hydroxycarbamide - treatment of myeloproliferative neoplasms

8

SFT

Oral Methotrexate - once weekly

8

SFT

Paediatric Oncology

8

3Ts

Mycophenolate

8

 

Chapter 9 - Nutrition and blood

 

BCAP

Alfacalcidol - treatment of hypocalcaemia due to hypoparathyroidism - Adults

9

BCAP

Lanthanum

9

BCAP

Renavit - treatment to prevent dialysis associated vitamin deficiencies in dialysis patients

9

BCAP

Sevelamer - treatment of hyperphosphataemia in adult patients with chronic kidney disease

9

 

Chapter 10 - Musculoskeletal and joint diseases

 

3Ts

Hydroxychloroquine - treatment of rheumatoid arthritis, juvenile chronic arthritis etc

10

3Ts

Leflunomide - treatment of Rheumatoid Arthritis, psoriatic arthritis etc

10

3Ts

Penicillamine - treatment of hypocalcaemia due to hypoparathyroidism - Adults

10

BCAP

DMARD monitoring

10

SFT

DMARD monitoring

10

SFT

Riluzole - in the management of Motor Neurone Disease

10

 

Chapter 13 - Skin

 

BCAP

Larvae - treatment of wounds with Larvae therapy

13

3Ts

Hydroxychloroquine - for discoid & systemic lupus erythematosis, sarcoidosis etc

13

 

Chapter 16 - Paediatrics

 

BSW

BSW CCG Paediatric ADHD Shared Care Agreement

16

 

 

 

 Details...
23.06  Documents Type A
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG
Blueteq
High Cost Drug Approval System

Traffic Light Status Information

Status Description

Red

RED - Hospital only to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment.  

Amber

Amber medicines are considered suitable for GP prescribing following specialist initiation or recommendation.  

Amber with Shared Care

Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.  

Green

These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.  

Self

Suitable for patient to be directed to buy themselves  

Grey

Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.   

Black

Not currently used. We intend to include this TLS in future to highlight where a decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications. Do not prescribe.  

Red Specialist Centre

Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.  

netFormulary